NRXP
NRX Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $124.26M
- Employees
- 29
- Latest publication
- 2026-09-29
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,101,000USD | 1,068,000USD | 983,000USD | 242,000USD | 0USD | 4,000USD | 4,000USD | 0USD |
| Cost Of Revenue | 675,000USD | 796,000USD | 508,000USD | 138,000USD | — | 2,000USD | 1,000USD | 2,000USD |
| Gross Profit | 426,000USD | 272,000USD | 475,000USD | 104,000USD | — | 2,000USD | -1,000USD | -2,000USD |
| Research Development | 2,116,000USD | 1,309,000USD | 558,000USD | 1,429,000USD | 987,000USD | 804,000USD | 1,036,000USD | 611,000USD |
| Selling General Administrative | 4,745,000USD | 3,813,000USD | 4,569,000USD | 2,808,000USD | 2,743,000USD | 2,943,000USD | 2,598,000USD | 2,411,000USD |
| Total Operating Expenses | 6,931,000USD | 5,020,000USD | 5,069,000USD | 4,222,000USD | 3,730,000USD | 3,847,000USD | 3,633,000USD | 3,020,000USD |
| Operating Income | -6,505,000USD | -4,748,000USD | -4,594,000USD | -4,118,000USD | -3,730,000USD | -3,847,000USD | -3,634,000USD | -3,022,000USD |
| Total Other Income Expense Net | -10,018,000USD | 3,318,000USD | 4,954,000USD | -1,772,000USD | -13,851,000USD | -1,665,000USD | -5,444,000USD | 1,399,000USD |
| Interest Income | 6,000USD | 5,000USD | 4,000USD | 2,000USD | 2,000USD | 4,000USD | 4,000USD | 6,000USD |
| Interest Expense | 240,000USD | 233,000USD | 671,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Litigation Settlement Expense | 4,000USD | — | — | — | — | — | — | — |
| Income Before Tax | -16,523,000USD | -1,430,000USD | 360,000USD | -5,890,000USD | -17,581,000USD | -5,512,000USD | -9,078,000USD | -1,623,000USD |
| Income Tax Expense | 0USD | — | — | — | — | — | — | — |
| Equity Method Income Loss | 3,000USD | — | — | — | — | — | — | — |
| Net Income | -16,520,000USD | -1,430,000USD | 360,000USD | -5,890,000USD | -17,581,000USD | -5,512,000USD | -9,078,000USD | -1,623,000USD |
| Net Interest Income | — | -228,000USD | -667,000USD | 2,000USD | 2,000USD | 4,000USD | 4,000USD | 6,000USD |
| Net Income From Continuing Ops | — | -1,430,000USD | 360,000USD | -5,890,000USD | -17,581,000USD | -5,512,000USD | -9,078,000USD | -1,623,000USD |
| Ebit | — | -4,748,000USD | -4,594,000USD | -4,118,000USD | -3,730,000USD | -9,078,000USD | -9,078,000USD | -1,623,000USD |
| Ebitda | — | -4,583,000USD | -4,494,000USD | -4,077,000USD | -17,581,000USD | -5,512,000USD | -9,077,000USD | -1,621,000USD |
| Depreciation And Amortization | — | 165,000USD | 100,000USD | 41,000USD | — | 1,000USD | 1,000USD | 2,000USD |
| Reconciled Depreciation | — | 165,000USD | 100,000USD | 43,000USD | -1,000USD | 1,000USD | 1,000USD | 2,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 1,000USD | 1,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,225,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Cost Of Revenue | 505,000USD | 5,000USD | 5,000USD | 4,000USD | 2,000USD | 2,000USD | — | 1,006,503USD |
| Gross Profit | 720,000USD | -5,000USD | -5,000USD | -4,000USD | -2,000USD | -2,000USD | — | -1,006,503USD |
| Research Development | 3,777,000USD | 6,199,000USD | 13,371,000USD | 17,027,000USD | 20,257,000USD | 10,625,000USD | 3,496USD | — |
| Selling General Administrative | 13,061,000USD | 13,505,000USD | 14,216,000USD | 27,370,000USD | 74,944,000USD | 11,436,000USD | 2,767USD | 1,006,500USD |
| Total Operating Expenses | 16,944,000USD | 19,699,000USD | 27,582,000USD | 44,331,000USD | 95,199,000USD | 22,059,000USD | 713,187USD | 1,006,502USD |
| Operating Income | -16,224,000USD | -19,704,000USD | -27,587,000USD | -44,335,000USD | -95,201,000USD | -22,061,000USD | -713,187USD | -1,006,500USD |
| Interest Income | 12,000USD | 44,000USD | 550,000USD | 249,000USD | 0USD | 138,760USD | 1,205,820USD | 1,088,920USD |
| Interest Expense | 671,000USD | 1,079,000USD | 120,000USD | 4,581,000USD | 18,000USD | 56,000USD | 0USD | 0USD |
| Net Interest Income | -659,000USD | -186,000USD | 513,000USD | 249,000USD | -18,000USD | -56,000USD | — | — |
| Income Before Tax | -28,622,000USD | -25,126,000USD | -30,150,000USD | -39,754,000USD | -93,063,000USD | -51,777,000USD | 492,633USD | 82,412USD |
| Net Income | -28,622,000USD | -25,126,000USD | -30,150,000USD | -39,754,000USD | -93,063,000USD | -51,777,000USD | 408,427USD | 66,101USD |
| Net Income From Continuing Ops | -28,622,000USD | -25,126,000USD | -36,059,000USD | -39,754,000USD | -93,063,000USD | -1,089,510USD | — | — |
| Ebit | -27,951,000USD | -24,047,000USD | -30,030,000USD | -39,754,000USD | -93,045,000USD | -51,721,000USD | -713,188USD | -1,006,503USD |
| Ebitda | -27,808,000USD | -24,042,000USD | -30,025,000USD | -39,750,000USD | -93,043,000USD | -51,719,000USD | 492,633USD | 82,412USD |
| Depreciation And Amortization | 143,000USD | 5,000USD | 5,000USD | 4,000USD | 2,000USD | 2,000USD | 1USD | 1,088,915USD |
| Reconciled Depreciation | 143,000USD | 5,000USD | 5,000USD | 4,000USD | 2,000USD | 2,000USD | — | — |
| Total Other Income Expense Net | -12,398,000USD | -5,422,000USD | -2,563,000USD | 4,581,000USD | 2,138,000USD | -29,716,000USD | 1,205,820USD | 1,088,912USD |
| Selling And Marketing Expenses | — | — | 5,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -9,000USD | -4,581,000USD | -21,348,000USD | -39,430,000USD | 84,206USD | 16,311USD |
| Tax Provision | — | — | — | 0USD | 0USD | 17,840USD | 84,210USD | 16,310USD |
| Net Income Applicable To Common Shares | — | — | — | -39,754,000USD | -348,885,000USD | -51,776,904USD | -6,729,161USD | 66,100USD |
| Non Operating Income Net Other | — | — | — | — | — | -303,027USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 34,160,000USD | 11,903,000USD | 12,956,000USD | 14,996,000USD | 4,838,000USD | 7,590,000USD | 3,651,000USD | 4,462,000USD |
| Cash And Equivalents | 26,686,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 29,158,000USD | 7,361,000USD | 8,892,000USD | 11,947,000USD | 4,590,000USD | 7,256,000USD | 3,302,000USD | 4,106,000USD |
| Other Current Assets | 2,266,000USD | 467,000USD | 934,000USD | 4,524,000USD | 1,680,000USD | 1,708,000USD | 1,859,000USD | 2,454,000USD |
| Other Non Current Assets | 224,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 34,330,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 33,874,000USD | 25,176,000USD | 28,578,000USD | 40,593,000USD | 40,453,000USD | 32,751,000USD | 21,863,000USD | 20,299,000USD |
| Total Stockholder Equity | -170,000USD | -13,816,000USD | -15,937,000USD | -25,755,000USD | -35,615,000USD | -25,161,000USD | -23,223,000USD | -18,822,000USD |
| Total Equity Including Noncontrolling Interest | -170,000USD | — | — | — | — | — | — | — |
| Net Receivables | 206,000USD | 181,000USD | 161,000USD | 239,000USD | — | — | 0USD | 6,000USD |
| Property Plant Equipment Net | 919,000USD | 936,000USD | 696,000USD | 350,000USD | — | — | 10,000USD | — |
| Goodwill | 1,793,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 832,000USD | 879,000USD | 925,000USD | 1,777,000USD | — | — | — | — |
| Accounts Payable | 3,146,000USD | 4,399,000USD | 4,270,000USD | 4,257,000USD | 3,630,000USD | 4,311,000USD | 4,130,000USD | 4,866,000USD |
| Common Stock | 43,000USD | 33,000USD | 32,000USD | 28,000USD | 19,000USD | 17,000USD | 15,000USD | 11,000USD |
| Retained Earnings | -324,845,000USD | -308,325,000USD | -306,895,000USD | -307,256,000USD | -301,366,000USD | -283,785,000USD | -278,273,000USD | -269,195,000USD |
| Total Liab | — | 25,719,000USD | 28,893,000USD | 40,751,000USD | 40,453,000USD | 32,751,000USD | 26,874,000USD | 23,284,000USD |
| Other Current Liab | — | 20,386,000USD | 23,992,000USD | 36,147,000USD | 26,591,000USD | 20,043,000USD | 16,167,000USD | 11,749,000USD |
| Capital Stock | — | 33,000USD | 32,000USD | 28,000USD | 19,000USD | 17,000USD | 15,000USD | 11,000USD |
| Good Will | — | 1,793,000USD | 1,793,000USD | 610,000USD | — | — | 0USD | — |
| Cash | — | 6,713,000USD | 7,797,000USD | 7,184,000USD | 2,910,000USD | 5,548,000USD | 1,443,000USD | 1,646,000USD |
| Cash And Short Term Investments | — | 6,713,000USD | 7,797,000USD | 7,184,000USD | 2,910,000USD | 5,548,000USD | 1,443,000USD | 1,646,000USD |
| Net Debt | — | -5,779,000USD | -7,166,000USD | -6,837,000USD | 7,322,000USD | 2,849,000USD | 5,134,000USD | 5,023,000USD |
| Short Term Debt | — | 391,000USD | 316,000USD | 189,000USD | 10,232,000USD | 8,397,000USD | 1,566,000USD | 3,684,000USD |
| Short Long Term Debt Total | — | 934,000USD | 631,000USD | 347,000USD | 10,232,000USD | 8,397,000USD | 6,577,000USD | 6,669,000USD |
| Long Term Investments | — | 399,000USD | 397,000USD | — | — | — | 0USD | — |
| Property Plant Equipment Gross | — | 1,242,000USD | 696,000USD | 419,000USD | — | — | 10,000USD | — |
| Common Stock Shares Outstanding | — | 32,325,323shares | 31,734,333shares | 22,231,178shares | 17,934,196shares | 16,410,000shares | 10,517,000shares | 10,974,000shares |
| Non Current Assets Total | — | 4,542,000USD | 4,064,000USD | 3,049,000USD | 248,000USD | 334,000USD | 349,000USD | 356,000USD |
| Non Current Liabilities Total | — | 543,000USD | 315,000USD | 158,000USD | 0USD | 5,011,000USD | 5,011,000USD | 2,985,000USD |
| Non Currrent Assets Other | — | 535,000USD | 253,000USD | 312,000USD | 248,000USD | 334,000USD | 349,000USD | 356,000USD |
| Net Working Capital | — | -17,815,000USD | -19,686,000USD | -28,646,000USD | -35,863,000USD | -25,495,000USD | -18,561,000USD | -16,193,000USD |
| Unclassified Equity | — | 294,443,000USD | 290,894,000USD | 281,445,000USD | 265,713,000USD | 258,590,000USD | 255,020,000USD | 250,351,000USD |
| Short Long Term Debt | — | — | — | 10,061,000USD | 10,232,000USD | 8,397,000USD | 1,566,000USD | 3,684,000USD |
| Unclassified Current Liabilities | — | — | — | -10,061,000USD | -10,232,000USD | -8,397,000USD | -1,566,000USD | -3,684,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 5,011,000USD | — | — |
| Long Term Debt | — | — | — | — | — | — | 5,011,000USD | 2,985,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 12,956,000USD | 3,651,000USD | 7,315,000USD | 25,816,000USD | 32,729,000USD | 2,941,000USD | 32,074,694USD | 70,796,159USD |
| Intangible Assets | 925,000USD | — | — | — | — | — | — | — |
| Other Current Assets | 934,000USD | 1,859,000USD | 2,283,000USD | 5,734,000USD | 5,109,000USD | 26,000USD | 69,483USD | 19,114USD |
| Total Liab | 28,893,000USD | 26,874,000USD | 19,048,000USD | 18,407,000USD | 11,923,000USD | 46,712,000USD | 2,574,205USD | 1,257,410USD |
| Total Stockholder Equity | -15,937,000USD | -23,223,000USD | -11,733,000USD | 7,409,000USD | 20,806,000USD | -43,771,000USD | 29,500,489USD | 69,538,749USD |
| Other Current Liab | 23,992,000USD | 16,167,000USD | 5,255,000USD | 5,806,000USD | 7,718,000USD | 42,710,358USD | 622,441USD | 16,311USD |
| Common Stock | 32,000USD | 15,000USD | 84,000USD | 67,000USD | 59,000USD | 43,000USD | 24,503,332USD | 64,541,467USD |
| Capital Stock | 32,000USD | 15,000USD | 87,000USD | 67,000USD | 59,000USD | 43,000USD | — | — |
| Retained Earnings | -306,895,000USD | -278,273,000USD | -253,147,000USD | -222,997,000USD | -183,243,000USD | -90,180,000USD | 369,495USD | -38,932USD |
| Good Will | 1,793,000USD | 0USD | — | — | — | — | — | — |
| Cash | 7,797,000USD | 1,443,000USD | 4,595,000USD | 20,054,000USD | 27,605,000USD | 1,859,000USD | 6USD | 11,079USD |
| Cash And Short Term Investments | 7,797,000USD | 1,443,000USD | 4,595,000USD | 20,054,000USD | 27,605,000USD | 1,859,000USD | 6USD | 11,079USD |
| Total Current Assets | 8,892,000USD | 3,302,000USD | 6,884,000USD | 25,795,000USD | 32,714,000USD | 2,930,000USD | 69,489USD | 30,193USD |
| Total Current Liabilities | 28,578,000USD | 21,863,000USD | 19,048,000USD | 15,585,000USD | 11,923,000USD | 46,164,000USD | 622,441USD | 567,410USD |
| Net Debt | -7,166,000USD | 5,134,000USD | 4,566,000USD | -9,529,000USD | -27,087,000USD | -1,062,000USD | 1,951,758USD | 678,921USD |
| Short Term Debt | 316,000USD | 1,566,000USD | 9,161,000USD | 7,703,000USD | 518,000USD | 249,000USD | — | — |
| Short Long Term Debt Total | 631,000USD | 6,577,000USD | 9,161,000USD | 10,525,000USD | 518,000USD | 797,000USD | 1,951,764USD | 690,000USD |
| Long Term Investments | 397,000USD | 0USD | — | — | — | — | — | — |
| Net Receivables | 161,000USD | 0USD | 6,000USD | 7,000USD | 0USD | 831,000USD | — | — |
| Accounts Payable | 4,270,000USD | 4,130,000USD | 4,632,000USD | 2,076,000USD | 3,687,000USD | 3,153,000USD | 622,441USD | 551,099USD |
| Property Plant Equipment Net | 633,000USD | 10,000USD | — | — | — | — | — | — |
| Property Plant Equipment Gross | 696,000USD | 10,000USD | — | — | — | — | — | — |
| Common Stock Shares Outstanding | 21,401,683shares | 10,517,000shares | 7,576,000shares | 65,767,000shares | 46,918,000shares | 546,586shares | 508,835shares | 892,496shares |
| Non Current Assets Total | 4,064,000USD | 349,000USD | 431,000USD | 21,000USD | 15,000USD | 11,000USD | 32,005,205USD | 70,765,966USD |
| Non Current Liabilities Total | 315,000USD | 5,011,000USD | 0USD | 2,822,000USD | 4,205,000USD | 548,000USD | 1,951,764USD | 690,000USD |
| Non Currrent Assets Other | 316,000USD | 349,000USD | 431,000USD | 21,000USD | 15,000USD | 11,000USD | 1USD | -234,034USD |
| Net Working Capital | -19,686,000USD | -18,561,000USD | -12,164,000USD | 10,210,000USD | 20,791,000USD | -43,234,000USD | — | — |
| Unclassified Equity | 290,894,000USD | 255,020,000USD | 241,246,000USD | 230,272,000USD | 203,931,000USD | 46,323,000USD | 29,130,996USD | 5,036,214USD |
| Short Long Term Debt | — | 1,566,000USD | 9,161,000USD | 7,703,000USD | 518,000USD | 249,000USD | — | — |
| Long Term Debt | — | 5,011,000USD | — | 2,822,000USD | — | 2,672,040USD | 1,951,760USD | 690,000USD |
| Unclassified Current Liabilities | — | -1,566,000USD | -9,161,000USD | -7,703,000USD | -3,362,000USD | — | — | — |
| Inventory | — | — | -6,000USD | -7,000USD | — | 214,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | -3,000USD | — | — | — | -24,503,334USD | — |
| Other Assets | — | — | — | 0USD | 15,000USD | 0USD | 10,930USD | — |
| Net Tangible Assets | — | — | — | 7,409,000USD | 20,806,000USD | -43,780,843USD | -4,853,317USD | — |
| Current Deferred Revenue | — | — | — | — | 2,844,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | 4,205,000USD | -2,124,040USD | — | — |
| Short Term Investments | — | — | — | — | — | 5,967,947USD | 32,005,205USD | 70,765,966USD |
| Unclassified Current Assets | — | — | — | — | — | -5,967,947USD | -32,005,205USD | -70,765,966USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | 31,994,274USD | 70,765,966USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 134,000USD |
| Stock Based Compensation | 290,000USD |
| Other Non Cash Items | 0USD |
| Change To Account Receivables | -98,000USD |
| Change To Liabilities | -1,424,000USD |
| Change In Working Capital | -2,614,000USD |
| Operating Cash Flow | -13,170,000USD |
| Capital Expenditures | -897,000USD |
| Investing Cash Flow | -897,000USD |
| Financing Cash Flow | 32,956,000USD |
| Change In Cash | 18,889,000USD |
| End Cash Flow | 26,686,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,430,000USD | 360,000USD | -5,890,000USD | -17,580,000USD | -5,512,000USD | -9,078,000USD | -1,623,000USD | -7,897,000USD |
| Depreciation | 165,000USD | 100,000USD | 41,000USD | -1,000USD | 1,000USD | 1,000USD | 2,000USD | 1,000USD |
| Stock Based Compensation | 151,000USD | 81,000USD | 68,000USD | 67,000USD | 12,000USD | 43,000USD | 104,000USD | 97,000USD |
| Other Non Cash Items | -3,512,000USD | -5,612,000USD | 2,391,000USD | 14,001,000USD | 2,020,000USD | 7,022,000USD | -1,141,000USD | 2,190,000USD |
| Change To Account Receivables | -48,000USD | 36,000USD | 12,000USD | — | 0USD | — | — | — |
| Change In Working Capital | 331,000USD | 1,358,000USD | 567,000USD | -516,000USD | 548,000USD | -86,000USD | 352,000USD | 2,104,000USD |
| Total Cash From Operating Activities | -4,295,000USD | -3,713,000USD | -2,891,000USD | -4,028,000USD | -3,480,000USD | -2,098,000USD | -2,306,000USD | -3,505,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -4,295,000USD | -3,713,000USD | -2,891,000USD | -4,028,000USD | -3,480,000USD | -2,098,000USD | -2,306,000USD | -3,505,000USD |
| Investments | -213,000USD | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | -213,000USD | -249,000USD | -2,561,000USD | — | — | — | — | — |
| Net Borrowings | 0USD | 196,000USD | -575,000USD | 378,000USD | 4,680,000USD | 884,000USD | -224,000USD | — |
| Total Cash From Financing Activities | 3,424,000USD | 4,575,000USD | 9,726,000USD | 1,390,000USD | 7,585,000USD | 1,895,000USD | 2,054,000USD | 4,083,999USD |
| Issuance Of Capital Stock | 3,424,000USD | 1,641,000USD | 9,952,000USD | 1,012,000USD | 3,255,000USD | 0USD | 219,000USD | 3,142,000USD |
| Change In Cash | -1,084,000USD | 613,000USD | 4,274,000USD | -2,638,000USD | 4,105,000USD | -203,000USD | -252,000USD | 579,000USD |
| Begin Period Cash Flow | 7,797,000USD | 7,184,000USD | 2,910,000USD | 5,548,000USD | 1,443,000USD | 1,646,000USD | 1,898,000USD | 1,319,000USD |
| End Period Cash Flow | 6,713,000USD | 7,797,000USD | 7,184,000USD | 2,910,000USD | 5,548,000USD | 1,443,000USD | 1,646,000USD | 1,898,000USD |
| Other Cashflows From Investing Activities | -213,000USD | -432,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | 3,424,000USD | 1,000USD | -1,000USD | — | -350,000USD | 1,011,000USD | 2,368,000USD | — |
| Unclassified Financing Cash Flow | -3,424,000USD | 2,737,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | -2,561,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -28,622,000USD | -25,126,000USD | -30,150,000USD | -39,754,000USD | -93,063,000USD | -51,777,000USD | 408,427USD | 66,101USD |
| Depreciation | 143,000USD | 5,000USD | 5,000USD | 4,000USD | 2,000USD | 2,000USD | 1USD | — |
| Stock Based Compensation | 228,000USD | 486,000USD | 387,000USD | 3,628,000USD | 7,785,000USD | 730,000USD | 934USD | — |
| Other Non Cash Items | 12,730,000USD | 8,707,000USD | 2,937,000USD | -4,332,000USD | 52,471,000USD | 45,327,000USD | -1,205,820USD | -1,554,343USD |
| Change To Account Receivables | 48,000USD | 0USD | — | 0USD | 831,000USD | -831,000USD | -831,390USD | — |
| Change In Working Capital | 1,409,000USD | 5,291,000USD | 5,164,000USD | 699,000USD | -4,898,000USD | 3,453,000USD | 4,662USD | 549,627USD |
| Total Cash From Operating Activities | -14,112,000USD | -10,637,000USD | -21,657,000USD | -39,755,000USD | -37,703,000USD | -2,265,000USD | -792,731USD | -473,187USD |
| Capital Expenditures | 0USD | 0USD | -3,000USD | -10,000USD | -7,000USD | -2,000USD | -1USD | 0USD |
| Free Cash Flow | -14,112,000USD | -10,637,000USD | -21,660,000USD | -39,765,000USD | -37,710,000USD | -2,267,000USD | -792,730USD | -473,187USD |
| Investments | -432,000USD | 0USD | -3,000USD | -10,000USD | -7,000USD | -282,626USD | — | — |
| Total Cashflows From Investing Activities | -2,810,000USD | — | -3,000USD | -10,000USD | -7,000USD | -2,000USD | 40,246,581USD | -647,608USD |
| Net Borrowings | 4,679,000USD | -1,496,000USD | -3,092,000USD | 9,502,000USD | -1,276,000USD | 619,842USD | 619,842USD | — |
| Total Cash From Financing Activities | 23,276,000USD | 7,485,000USD | 6,201,000USD | 32,214,000USD | 63,456,000USD | 3,249,000USD | -39,464,923USD | 682,500USD |
| Issuance Of Capital Stock | 15,860,000USD | 5,911,000USD | 9,385,000USD | 22,702,000USD | 36,983,000USD | 2,629,000USD | — | — |
| Change In Cash | 6,354,000USD | -3,152,000USD | -15,459,000USD | -7,551,000USD | 25,746,000USD | 982,000USD | -11,073USD | -438,295USD |
| Begin Period Cash Flow | 1,443,000USD | 4,595,000USD | 20,054,000USD | 27,605,000USD | 1,859,000USD | 877,000USD | 11,079USD | 449,374USD |
| End Period Cash Flow | 7,797,000USD | 1,443,000USD | 4,595,000USD | 20,054,000USD | 27,605,000USD | 1,859,000USD | 6USD | 11,079USD |
| Other Cashflows From Investing Activities | -432,000USD | — | — | 10,000USD | 7,000USD | 26,176,022USD | 4USD | -647,608USD |
| Other Cashflows From Financing Activities | 23,276,000USD | 3,070,000USD | 1,171,000USD | 10,000USD | 27,749,000USD | 50,000USD | 1,261,764USD | 682,500USD |
| Unclassified Investing Cash Flow | -1,946,000USD | — | — | — | — | -25,893,396USD | 40,246,578USD | — |
| Unclassified Financing Cash Flow | -20,539,000USD | — | -1,263,000USD | — | — | 28,876,376USD | — | — |
| Change To Liabilities | — | — | — | 0USD | -19,000USD | 1,183,143USD | -52,181USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | -26,297,218USD | -40,726,687USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 460USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Procedures | 308,000 | USD | 0001437749-26-017397 |
| Q1 2026Quarterly · 2026-03-31 | Product | Therapy | 760,000 | USD | 0001437749-26-017397 |
| FY 2025Yearly · 2025-12-31 | Product | Procedures | 371,000 | USD | 0001437749-26-009418 |
| FY 2025Yearly · 2025-12-31 | Product | Therapy | 854,000 | USD | 0001437749-26-009418 |
| Q3 2025Quarterly · 2025-09-30 | Product | Procedures | 90,000 | USD | 0001437749-25-035210 |
| Q3 2025Quarterly · 2025-09-30 | Product | Therapy | 152,000 | USD | 0001437749-25-035210 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.